Atropos Health and Syndesis Health announced today the expansion of the Atropos Evidence Network to include global RWD from Syndesis’s Syntium platform, adding to Atropos’s growing offering of on-demand evidence for healthcare and life sciences, delivered directly to clinical practitioners, on the ground where it matters most.
“Our partnership with Atropos Health underscores our commitment to advancing precision medicine by leveraging Syndesis Health’s extensive datasets,” said Josh Sutton, CEO of Syndesis Health. “With data spanning 15 countries outside of the US and approximately 35 million patients, we are uniquely positioned to ensure that the advancements in precision medicine reflect both geographic and ethnic diversity. By integrating these diverse datasets into the Atropos Evidence Network, we can generate more comprehensive and inclusive real-world evidence, ultimately leading to more personalized and effective treatments for patients around the globe.”